Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: Meta-analysis of postprogression survival for first-line chemotherapy

被引：0
|
作者：
Kasuga, Akiyoshi [1 ]
Hamamoto, Yasuo [1 ]
Takeuchi, Ayano [2 ]
Kawasaki, Kenta [1 ]
Suzuki, Takeshi [1 ]
Hirata, Kenro [1 ]
Sukawa, Yasutaka [1 ]
Takaishi, Hiromasa [1 ]
Kanai, Takanori [1 ]
机构：
[1] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan
[2] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1718
引用
收藏
页码：257 / 257
页数：1
相关论文
共 50 条
  • [31] Perioperative chemotherapy more of a benefit for overall survival than adjuvant chemotherapy for operable gastric cancer: an updated Meta-analysis
    Ya’nan Yang
    Xue Yin
    Lei Sheng
    Shan Xu
    Lingling Dong
    Lian Liu
    Scientific Reports, 5
  • [32] Mutational Profile Evaluates Response and Survival to First-Line Chemotherapy in Lung Cancer
    He, Yayi
    Song, Lele
    Wang, Hao
    Chen, Peixin
    Liu, Yu
    Sun, Hui
    Li, Xiaobin
    Dang, Shiying
    Liu, Guifeng
    Liu, Xinyi
    Chen, Shifu
    Zhang, Xiaoni
    Hofman, Paul
    Uchino, Junji
    Park, Henry S.
    Pacheco, Jose M.
    Tabbo, Fabrizio
    Xu, Mingyan
    Dai, Jiawei
    He, Kan
    Yang, Yang
    Zhou, Caicun
    ADVANCED SCIENCE, 2021, 8 (04)
  • [33] Bevacizumab in combination with first-line chemotherapy in patients with metastatic colorectal cancer: a meta-analysis
    Hu, W.
    Xu, W. -S.
    Liao, X. -F.
    He, H. -J.
    MINERVA CHIRURGICA, 2015, 70 (06) : 451 - 458
  • [34] AN ESTIMATION OF THE POPULATION SURVIVAL BENEFIT OF FIRST-LINE CHEMOTHERAPY FOR UPPER GASTROINTESTINAL CANCER
    Viet Do
    Weng Ng
    Delaney, Geoff P.
    Barton, Michael B.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 148 - 148
  • [35] Conditional Survival of Patients Treated With First-Line Chemotherapy for Metastatic Urothelial Cancer
    Santoni, Matteo
    Crabb, Simon J.
    Conti, Alessandro
    Rossi, Lorena
    Burattini, Luciano
    Conteduca, Vincenza
    Chau, Caroline
    Burgio, Salvatore L.
    Muzzonigro, Giovanni
    Cascinu, Stefano
    De Giorgi, Ugo
    CLINICAL GENITOURINARY CANCER, 2015, 13 (03) : 244 - 249
  • [36] Impact of cachexia on survival before first-line chemotherapy for metastatic breast cancer
    Nozawa, Kazuki
    Isogai, Ayaka
    Takatsuka, Daiki
    Endo, Yuka
    Ozaki, Yuri
    Horisawa, Nanae
    Kataoka, Ayumi
    Kotani, Haruru
    Yoshimura, Akiyo
    Hattori, Masaya
    Sawaki, Masataka
    Iwata, Hiroji
    ANNALS OF ONCOLOGY, 2022, 33 : S491 - S492
  • [37] The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis
    ter Veer, Emil
    Mohammad, Nadia Haj
    van Valkenhoef, Gert
    Ngai, Lok Lam
    Mali, Rosa M. A.
    Anderegg, Maarten C.
    van Oijen, Martijn G. H.
    van Laarhoven, Hanneke W. M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (10):
  • [38] An estimation of the population survival benefit of first-line chemotherapy and immunotherapy for breast cancer
    Delaney, G. P.
    Do, V.
    Ng, W.
    Barton, M. B.
    CANCER RESEARCH, 2017, 77
  • [39] Trend in overall survival from the start of first-line chemotherapy in patients with metastatic urothelial carcinoma
    Yamamoto, Shoma
    Kato, Minoru
    Matsue, Taisuke
    Yukimatsu, Nao
    Takeyama, Yuji
    Otoshi, Taiyo
    Yamasaki, Takeshi
    Kuratsukuri, Katsuyuki
    Uchida, Junji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (02) : 221 - 224
  • [40] Docetaxel versus mitoxantrone as first-line chemotherapy for hormone-refractory prostate cancer (HRPC) patients. A meta-analysis of 3-year overall survival results
    Oudard, S
    Banu, E
    Banu, A
    Scotte, F
    Levy, E
    Medioni, J
    Guillevin, EF
    Ayllon, J
    Arakelyan, N
    Andrieu, JM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 411S - 411S
12345